A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study

Noelle K. LoConte, Kyle D. Holen, William R. Schelman, Daniel Mulkerin, Dustin A. Deming, Hilary R. Hernan, Anne M. Traynor, Timothy F. Goggins, David L. Groteluschen, Kurt R. Oettel,

Investigational New Drugs · 2012 · 11 citations · 27 references

DOIFull text

Open access

Concepts

References

27